In the medical trial knowledge with Xyrem in narcolepsy/cataplexy individuals at therapeutic doses, two sufferers documented anxiety and just one claimed insomnia following abrupt discontinuation on the termination on the scientific demo; in the two people with panic, the frequency of cataplexy expe